TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Syncom Formulation (India) Ltd. ( (IN:SYNCOMF) ) is now available.
Syncom Formulations (India) Limited has announced the successful acquisition of a commercial property, specifically the entire 3rd Floor of Trade Star on Andheri-Kurla Road, Mumbai, for a total consideration of ₹51.7 crore. This strategic acquisition, accepted by HDFC Bank Ltd., is expected to enhance the company’s operational capabilities and strengthen its market position.
More about Syncom Formulation (India) Ltd.
Syncom Formulations (India) Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of pharmaceutical products. The company is known for its commitment to quality and innovation in the healthcare sector.
Average Trading Volume: 202,555
Technical Sentiment Signal: Sell
Current Market Cap: 14.91B INR
For detailed information about SYNCOMF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “Soulless” Options Put on Notice: Starbucks Stock (NASDAQ:SBUX) Notches Up as Niccol Continues to Plead Third-Place
- “We Anticipate These Pressures Will Persist”: Home Depot Stock (NYSE:HD) Gains Despite Housing Market Troubles
- Nvidia or Palantir: Billionaire Chris Rokos Pours Hundreds of Millions Into One Top AI Stock